• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 在 Caco-2 细胞中的感染短时间效应。

Effect of Short Time of SARS-CoV-2 Infection in Caco-2 Cells.

机构信息

Institute for Maternal and Child Health IRCCS Burlo Garofolo, 34137 Trieste, Italy.

Division of Laboratory Medicine, University Hospital Giuliano Isontina, 34149 Trieste, Italy.

出版信息

Viruses. 2022 Mar 29;14(4):704. doi: 10.3390/v14040704.

DOI:10.3390/v14040704
PMID:35458434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9031642/
Abstract

Coronavirus disease 19 (COVID-19) clinical manifestations include the involvement of the gastrointestinal tract, affecting around 10% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected children. In the present work, the consequence of a short time of viral absorption (5, 15, 30 and 60 min) was tested on the Caco-2 intestinal epithelial cell line. Our findings show that Caco-2 cells are highly permissive to SARS-CoV-2 infection, even after 5 min of viral inoculation at a multiplicity of infection of 0.1. No cytopathic effect was evident during the subsequent 7 days of monitoring; nevertheless, the immunofluorescence staining for the viral nucleocapsid confirmed the presence of intracellular SARS-CoV-2. Our findings highlight the very short time during which SARS-CoV-2 is able to infect these cells in vitro.

摘要

新型冠状病毒病(COVID-19)的临床表现包括胃肠道受累,约影响 10%严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染的儿童。在本工作中,我们测试了病毒吸收(5、15、30 和 60 分钟)短时间对 Caco-2 肠上皮细胞系的影响。我们的研究结果表明,Caco-2 细胞对 SARS-CoV-2 感染高度易感,即使在感染复数为 0.1 时病毒接种 5 分钟后也是如此。在随后的 7 天监测过程中,没有明显的细胞病变效应;然而,针对病毒核衣壳的免疫荧光染色证实了细胞内 SARS-CoV-2 的存在。我们的研究结果强调了 SARS-CoV-2 在体外感染这些细胞的极短时间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb6/9031642/f9edcbc96504/viruses-14-00704-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb6/9031642/fdb49f77586f/viruses-14-00704-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb6/9031642/083fd2a974f9/viruses-14-00704-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb6/9031642/8d0bf3be4902/viruses-14-00704-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb6/9031642/7827c8a2f2a7/viruses-14-00704-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb6/9031642/bf9ff5a01014/viruses-14-00704-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb6/9031642/78baf190471f/viruses-14-00704-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb6/9031642/1d885c10b7c3/viruses-14-00704-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb6/9031642/f9edcbc96504/viruses-14-00704-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb6/9031642/fdb49f77586f/viruses-14-00704-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb6/9031642/083fd2a974f9/viruses-14-00704-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb6/9031642/8d0bf3be4902/viruses-14-00704-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb6/9031642/7827c8a2f2a7/viruses-14-00704-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb6/9031642/bf9ff5a01014/viruses-14-00704-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb6/9031642/78baf190471f/viruses-14-00704-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb6/9031642/1d885c10b7c3/viruses-14-00704-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bb6/9031642/f9edcbc96504/viruses-14-00704-g008.jpg

相似文献

1
Effect of Short Time of SARS-CoV-2 Infection in Caco-2 Cells.SARS-CoV-2 在 Caco-2 细胞中的感染短时间效应。
Viruses. 2022 Mar 29;14(4):704. doi: 10.3390/v14040704.
2
SARS-CoV-2 Short-Time Infection Produces Relevant Cytopathic Effects in Vero E6 Cell Line.SARS-CoV-2 在vero E6 细胞系中短时间感染产生相关细胞病变效应。
Int J Environ Res Public Health. 2021 Aug 26;18(17):9020. doi: 10.3390/ijerph18179020.
3
DG enhances the lactoferrin anti-SARS-CoV-2 response in Caco-2 cells.DG 增强了 Caco-2 细胞中乳铁蛋白抗 SARS-CoV-2 的反应。
Gut Microbes. 2021 Jan-Dec;13(1):1961970. doi: 10.1080/19490976.2021.1961970.
4
COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection?新型冠状病毒肺炎与胃肠道:是感染源还是仅仅是感染新型冠状病毒后炎症过程的靶点?
World J Gastroenterol. 2021 Apr 14;27(14):1406-1418. doi: 10.3748/wjg.v27.i14.1406.
5
Fecal-oral transmission of SARS-CoV-2: review of laboratory-confirmed virus in gastrointestinal system.SARS-CoV-2 的粪-口传播:胃肠道系统中实验室确认病毒的综述。
Int J Colorectal Dis. 2021 Mar;36(3):437-444. doi: 10.1007/s00384-020-03785-7. Epub 2020 Oct 14.
6
Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells.在表达人肠道刷状缘的细胞中存在稳健且持久的 SARS-CoV-2 感染。
Emerg Microbes Infect. 2020 Dec;9(1):2169-2179. doi: 10.1080/22221751.2020.1827985.
7
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
8
Development of a novel mathematical model that explains SARS-CoV-2 infection dynamics in Caco-2 cells.开发一种新型数学模型,用于解释 SARS-CoV-2 在 Caco-2 细胞中的感染动力学。
PeerJ. 2023 Feb 1;11:e14828. doi: 10.7717/peerj.14828. eCollection 2023.
9
Duration of Respiratory and Gastrointestinal Viral Shedding in Children With SARS-CoV-2: A Systematic Review and Synthesis of Data.儿童 SARS-CoV-2 呼吸道和胃肠道病毒脱落持续时间:系统评价和数据综合。
Pediatr Infect Dis J. 2020 Sep;39(9):e249-e256. doi: 10.1097/INF.0000000000002814.
10
Specific Regulatory Motifs Network in SARS-CoV-2-Infected Caco-2 Cell Line, as a Model of Gastrointestinal Infections.SARS-CoV-2 感染的 Caco-2 细胞系中的特定调控基序网络,作为胃肠道感染的模型。
Cell Reprogram. 2022 Feb;24(1):26-37. doi: 10.1089/cell.2021.0055. Epub 2022 Jan 31.

引用本文的文献

1
Strain- and vaccine-specific effects of serum antibodies in the protection of intestinal SARS-CoV-2 infection.血清抗体在预防肠道 SARS-CoV-2 感染中的菌株特异性和疫苗特异性作用。
medRxiv. 2025 Mar 28:2025.03.24.25324570. doi: 10.1101/2025.03.24.25324570.
2
Vasoactive Intestinal Peptide (VIP) in COVID-19 Therapy-Shedding of ACE2 and TMPRSS2 via ADAM10.血管活性肠肽(VIP)在新冠病毒病(COVID-19)治疗中——通过ADAM10促使血管紧张素转换酶2(ACE2)和跨膜丝氨酸蛋白酶2(TMPRSS2)脱落
Int J Mol Sci. 2025 Mar 16;26(6):2666. doi: 10.3390/ijms26062666.
3
Preferential apical infection of Caco-2 intestinal cell monolayers by SARS-CoV-2 is associated with damage to cellular barrier integrity: Implications for the pathophysiology of COVID-19.

本文引用的文献

1
Development of a One-Step Qualitative RT-PCR Assay to Detect the SARS-CoV-2 Omicron (B.1.1.529) Variant in Respiratory Specimens.开发一种一步法定量逆转录聚合酶链反应检测法以检测呼吸道标本中的严重急性呼吸综合征冠状病毒2奥密克戎(B.1.1.529)变体
J Clin Microbiol. 2022 Mar 16;60(3):e0002422. doi: 10.1128/jcm.00024-22. Epub 2022 Feb 2.
2
Evaluation of Residual Infectivity after SARS-CoV-2 Aerosol Transmission in a Controlled Laboratory Setting.在控制实验室环境中评估 SARS-CoV-2 气溶胶传播后的剩余感染力。
Int J Environ Res Public Health. 2021 Oct 24;18(21):11172. doi: 10.3390/ijerph182111172.
3
SARS-CoV-2 Subgenomic RNAs: Characterization, Utility, and Perspectives.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对Caco-2肠细胞单层的优先顶端感染与细胞屏障完整性受损有关:对2019冠状病毒病病理生理学的启示。
PLoS One. 2025 Feb 10;20(2):e0313068. doi: 10.1371/journal.pone.0313068. eCollection 2025.
4
Gut microbe-host interactions in post-COVID syndrome: a debilitating or restorative partnership?新冠后综合征中的肠道微生物-宿主相互作用:是一种使人虚弱还是恢复性的伙伴关系?
Gut Microbes. 2024 Jan-Dec;16(1):2402544. doi: 10.1080/19490976.2024.2402544. Epub 2024 Sep 17.
5
How Deep Learning in Antiviral Molecular Profiling Identified Anti-SARS-CoV-2 Inhibitors.抗病毒分子谱分析中的深度学习如何识别抗SARS-CoV-2抑制剂。
Biomedicines. 2023 Nov 24;11(12):3134. doi: 10.3390/biomedicines11123134.
6
COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical Manifestations.新型冠状病毒肺炎与消化道:从病理生理学到临床表现。
Medicina (Kaunas). 2023 Sep 24;59(10):1709. doi: 10.3390/medicina59101709.
7
Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo.吡啶甲酸是一种广谱的包膜病毒进入抑制剂,可限制 SARS-CoV-2 和甲型流感病毒在体内的复制。
Cell Rep Med. 2023 Aug 15;4(8):101127. doi: 10.1016/j.xcrm.2023.101127. Epub 2023 Jul 17.
8
ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection.ACE2-EGFR-MAPK 信号通路参与 SARS-CoV-2 感染。
Life Sci Alliance. 2023 Jul 4;6(9). doi: 10.26508/lsa.202201880. Print 2023 Sep.
9
Development of a novel mathematical model that explains SARS-CoV-2 infection dynamics in Caco-2 cells.开发一种新型数学模型,用于解释 SARS-CoV-2 在 Caco-2 细胞中的感染动力学。
PeerJ. 2023 Feb 1;11:e14828. doi: 10.7717/peerj.14828. eCollection 2023.
10
Choosing a cellular model to study SARS-CoV-2.选择用于研究 SARS-CoV-2 的细胞模型。
Front Cell Infect Microbiol. 2022 Oct 21;12:1003608. doi: 10.3389/fcimb.2022.1003608. eCollection 2022.
SARS-CoV-2 亚基因组 RNA:特征、用途和展望。
Viruses. 2021 Sep 24;13(10):1923. doi: 10.3390/v13101923.
4
SARS-CoV-2 Short-Time Infection Produces Relevant Cytopathic Effects in Vero E6 Cell Line.SARS-CoV-2 在vero E6 细胞系中短时间感染产生相关细胞病变效应。
Int J Environ Res Public Health. 2021 Aug 26;18(17):9020. doi: 10.3390/ijerph18179020.
5
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.美国儿童多系统炎症综合征(MIS-C)与严重急性 COVID-19 患儿的特征和结局比较。
JAMA. 2021 Mar 16;325(11):1074-1087. doi: 10.1001/jama.2021.2091.
6
Culture of SARS-CoV-2 in a panel of laboratory cell lines, permissivity, and differences in growth profile.SARS-CoV-2 在一组实验室细胞系中的培养、易感性和生长特征差异。
Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):477-484. doi: 10.1007/s10096-020-04106-0. Epub 2021 Jan 2.
7
Gastrointestinal symptoms in patients with mild and severe COVID-19: a scoping review and meta-analysis.轻度和重度新冠肺炎患者的胃肠道症状:一项范围综述和荟萃分析
Gastroenterol Hepatol Bed Bench. 2020 Fall;13(4):321-330.
8
Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells.在表达人肠道刷状缘的细胞中存在稳健且持久的 SARS-CoV-2 感染。
Emerg Microbes Infect. 2020 Dec;9(1):2169-2179. doi: 10.1080/22221751.2020.1827985.
9
Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study.SARS-CoV-2 和 SARS-CoV 的比较嗜性、复制动力学和细胞损伤特征分析及其对 COVID-19 临床表现、传染性和实验室研究的影响:一项观察性研究。
Lancet Microbe. 2020 May;1(1):e14-e23. doi: 10.1016/S2666-5247(20)30004-5. Epub 2020 Apr 21.
10
SARS-CoV-2 cellular tropism.严重急性呼吸综合征冠状病毒2型的细胞嗜性。
Lancet Microbe. 2020 May;1(1):e2-e3. doi: 10.1016/S2666-5247(20)30008-2. Epub 2020 Apr 21.